143 related articles for article (PubMed ID: 28395400)
1. An opposing view on including high school students in a latent tuberculosis infection control program in Korea.
Bae JM
Epidemiol Health; 2017; 39():e2017015. PubMed ID: 28395400
[TBL] [Abstract][Full Text] [Related]
2. Vitamin D supplementation as a control program against latent tuberculosis infection in Korean high school students.
Kim EH; Bae JM
Epidemiol Health; 2018; 40():e2018035. PubMed ID: 30056639
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the usefulness of interferon-gamma release assays and the tuberculin skin test for the detection of latent Mycobacterium tuberculosis infections in Korean rheumatic patients who are candidates for biologic agents.
Kim JH; Won S; Choi CB; Sung YK; Song GG; Bae SC
Int J Rheum Dis; 2015 Mar; 18(3):315-22. PubMed ID: 25351815
[TBL] [Abstract][Full Text] [Related]
4. Proposal to Revise the Screening Test for Latent Tuberculosis Infection in Close Contacts at Elementary Schools in Korea.
Bae JM
J Prev Med Public Health; 2019 Jul; 52(4):272-275. PubMed ID: 31390691
[TBL] [Abstract][Full Text] [Related]
5. Latent tuberculosis infection: recent progress and challenges in South Korea.
Jeon D
Korean J Intern Med; 2020 Mar; 35(2):269-275. PubMed ID: 32131570
[TBL] [Abstract][Full Text] [Related]
6. Comparison of latent tuberculosis infection rate between contacts with active tuberculosis and non-contacts.
Yoo JW; Jo KW; Park GY; Shim TS
Respir Med; 2016 Feb; 111():77-83. PubMed ID: 26725461
[TBL] [Abstract][Full Text] [Related]
7. Latent tuberculosis infection screening and treatment in congregate settings (TB FREE COREA): protocol for a prospective observational study in Korea.
Min J; Kim HW; Stagg HR; Lipman M; Rangaka MX; Myong JP; Yim HW; Lim JU; Lee Y; Koo HK; Lee SS; Park JS; Cho KS; Kim JS
BMJ Open; 2020 Feb; 10(2):e034098. PubMed ID: 32075836
[TBL] [Abstract][Full Text] [Related]
8. Treatment guidelines for latent tuberculosis infection.
;
Kekkaku; 2014 Jan; 89(1):21-37. PubMed ID: 24654427
[TBL] [Abstract][Full Text] [Related]
9. Active tuberculosis risk with tumor necrosis factor inhibitors after treating latent tuberculosis.
Kwon M; Sung M; Kwon YJ; Song YG; Lee SW; Park MC; Park YB; Lee SK; Song JJ
J Clin Rheumatol; 2014 Mar; 20(2):68-73. PubMed ID: 24561408
[TBL] [Abstract][Full Text] [Related]
10. Focus on latent tuberculosis.
The Lancet Respiratory Medicine
Lancet Respir Med; 2016 Oct; 4(10):763. PubMed ID: 27707455
[No Abstract] [Full Text] [Related]
11. Latent Tuberculosis Infection Screening and 2-Year Outcome in Antiretroviral-Naive HIV-Infected Patients in a Low-Prevalence Country.
Bourgarit A; Baron G; Breton G; Tattevin P; Katlama C; Allavena C; Campa P; Ravaud P; Lortholary O; Carcelain G;
Ann Am Thorac Soc; 2015 Aug; 12(8):1138-45. PubMed ID: 26213798
[TBL] [Abstract][Full Text] [Related]
12. Randomized Controlled Trial of Clinical Guidelines Versus Interactive Decision-Support for Improving Medical Trainees' Confidence with Latent Tuberculosis Care.
Starke SJ; Martinez Rivera MB; Krishnan S; Shah M
J Gen Intern Med; 2024 May; 39(6):951-959. PubMed ID: 38062221
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of a school-based program for diagnosis and treatment of latent tuberculosis infection in immigrant children.
Minodier P; Lamarre V; Carle ME; Blais D; Ovetchkine P; Tapiero B
J Infect Public Health; 2010; 3(2):67-75. PubMed ID: 20701894
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness of the NICE guidelines for screening for latent tuberculosis infection: the QuantiFERON-TB Gold IGRA alone is more cost-effective for immigrants from high burden countries.
Hardy AB; Varma R; Collyns T; Moffitt SJ; Mullarkey C; Watson JP
Thorax; 2010 Feb; 65(2):178-80. PubMed ID: 19996345
[TBL] [Abstract][Full Text] [Related]
15. Tuberculosis elimination and the challenge of latent tuberculosis.
Matteelli A; Sulis G; Capone S; D'Ambrosio L; Migliori GB; Getahun H
Presse Med; 2017 Mar; 46(2 Pt 2):e13-e21. PubMed ID: 28279508
[TBL] [Abstract][Full Text] [Related]
16. Relevance of latent TB infection in areas of high TB prevalence.
Sharma SK; Mohanan S; Sharma A
Chest; 2012 Sep; 142(3):761-773. PubMed ID: 22948580
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis and management of latent tuberculosis infection in Asia: Review of current status and challenges.
Paton NI; Borand L; Benedicto J; Kyi MM; Mahmud AM; Norazmi MN; Sharma N; Chuchottaworn C; Huang YW; Kaswandani N; Le Van H; Lui GCY; Mao TE
Int J Infect Dis; 2019 Oct; 87():21-29. PubMed ID: 31301458
[TBL] [Abstract][Full Text] [Related]
18. Role of confirmatory interferon-gamma release assays in school outbreaks of tuberculosis in South Korea.
Kim HJ; Lee GH; Ryoo S; Oh SY; Lee JB; Kim JH; Shin C; Lee SH
Int J Tuberc Lung Dis; 2015 May; 19(5):576-81. PubMed ID: 25868027
[TBL] [Abstract][Full Text] [Related]
19. Towards optimal treatment for latent Mycobacterium tuberculosis infection.
Abubakar I; Chakaya J; Maeurer M; Zumla A
Lancet Respir Med; 2019 Mar; 7(3):195-197. PubMed ID: 30823969
[No Abstract] [Full Text] [Related]
20. Risk of tuberculosis in patients treated with anti-tumor necrosis factor therapy: a nationwide study in South Korea, a country with an intermediate tuberculosis burden.
Jung SM; Ju JH; Park MS; Kwok SK; Park KS; Kim HY; Yim HW; Park SH
Int J Rheum Dis; 2015 Mar; 18(3):323-30. PubMed ID: 25557144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
